These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11041023

  • 1. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC, Park KO, Kim YC, Na KJ, Song H, Bom HS.
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [Abstract] [Full Text] [Related]

  • 2. Dipyridamole modulated Tc-99m sestamibi lung SPECT in small cell lung cancer.
    Bom HS, Lim SC, Kim YC, Song HC, Min JJ, Jeong HJ, Kim JY, Lee J, Park KO.
    Clin Nucl Med; 1999 Feb; 24(2):97-101. PubMed ID: 9988065
    [Abstract] [Full Text] [Related]

  • 3. Technetium-99m-MIBI uptake in small cell lung cancer.
    Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO.
    J Nucl Med; 1998 Jan; 39(1):91-4. PubMed ID: 9443743
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Liu X, Zhang W, Yin W, Xiao Y, Zhou C, Hu Y, Geng S.
    Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
    Akgun A, Cok G, Karapolat I, Goksel T, Burak Z.
    Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of 99mTc-MIBI to predict chemotherapeutic response in patients with small cell lung carcinoma].
    Yamamoto Y, Nishiyama Y, Kawasaki Y, Satoh K, Takashima H, Ohkawa M, Tanabe M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Nov; 56(13):980-1. PubMed ID: 8969063
    [Abstract] [Full Text] [Related]

  • 7. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.
    Anticancer Res; 2008 Nov; 28(5B):3027-33. PubMed ID: 19031951
    [Abstract] [Full Text] [Related]

  • 8. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
    Kao A, Shiun SC, Hsu NY, Sun SS, Lee CC, Lin CC.
    Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
    [Abstract] [Full Text] [Related]

  • 9. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
    Changlai SP, Tsai CS, Ding HJ, Huang WT, Kao A, Hsu WH.
    Med Oncol; 2003 Nov; 20(3):247-53. PubMed ID: 14514974
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG, Osterlind K, Hansen HH, Cooper EH.
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [Abstract] [Full Text] [Related]

  • 12. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.
    Kao CH, ChangLai SP, Chieng PU, Yen TC.
    Cancer; 1998 Jul 01; 83(1):64-8. PubMed ID: 9655294
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
    Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, Kishi T, Matsuno S, Tanabe M.
    J Nucl Med; 1998 Sep 01; 39(9):1626-9. PubMed ID: 9744357
    [Abstract] [Full Text] [Related]

  • 14. The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.
    Dirlik A, Burak Z, Goksel T, Erinc R, Karakus H, Ozcan Z, Veral A, Ozhan M.
    Ann Nucl Med; 2002 Apr 01; 16(2):103-8. PubMed ID: 12043903
    [Abstract] [Full Text] [Related]

  • 15. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P, Joos G, Watripont P, Brusselle G, Pauwels R.
    Respiration; 1997 Apr 01; 64(1):102-7. PubMed ID: 9044484
    [Abstract] [Full Text] [Related]

  • 16. Monitoring the chemotherapeutic response in primary lung cancer using 99mTc-MIBI SPET.
    Yüksel M, Cermik TF, Karlikaya C, Salan A, Cakir E, Gültekin A, Berkarda S.
    Eur J Nucl Med; 2001 Jul 01; 28(7):799-806. PubMed ID: 11504075
    [Abstract] [Full Text] [Related]

  • 17. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
    Hsu WH, Yen RF, Kao CH, Shiun SC, Hsu NY, Lin CC, Lee CC.
    Oncology; 2002 Jul 01; 63(2):173-9. PubMed ID: 12239453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y, Wang Y, Li J, Hao X, Hu X.
    Zhongguo Fei Ai Za Zhi; 2016 Sep 20; 19(9):590-4. PubMed ID: 27666548
    [Abstract] [Full Text] [Related]

  • 20. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
    Ma Q, Min K, Wang T, Chen B, Wen Q, Wang F, Ji T, Gao S.
    Ann Nucl Med; 2015 Jul 20; 29(6):519-27. PubMed ID: 25911312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.